Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Airborne nitric oxide: inflammatory marker and aerocrine messenger in man.

Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Abstract Text:

    j o lundbergJ O Lundberg,

    1. In healthy subjects, exhaled NO originates mainly from the upper airways with only a minor contribution from the lower airways and the lungs. A large NO production takes place in the epithelium of the paranasal sinuses and this NO contributes considerably to the levels of NO found in nasally exhaled air. Immunohistochemical and mRNA in situ hybridisation studies suggest that sinus NO synthase is identical or very closely related to the human iNOS. Furthermore, the NOS activity in sinus mucosa is mostly Ca(2+)-independent. However, the regulation of sinus NOS expression seems to differ fundamentally from what has earlier been described for iNOS. Thus, sinus NOS is constitutively expressed and seems resistant to steroids. The high local NO concentrations in the nasal airways and the sinuses may help to protect against airborne infectious agents. Thus, airborne NO may represent the very first line of defence in the airways, possibly acting on pathogens even before they reach the mucosa. 2. Nasal concentrations of NO are markedly reduced in children with Kartagener's syndrome and in patients with CF. A simple chemiluminescence test test could be of help in early non-invasive diagnosis of these chronic airway diseases. 3. Inhaled endogenous NO, derived from the upper airways, may be involved in regulation of pulmonary function in man. NO will reach the lower airways and the lungs with the inspired air and at levels that are especially high during nasal breathing. This NO may act by enhancing blood flow preferentially in well ventilated areas of the lung, thus optimizing ventilation/perfusion matching. The involvement of autogenous NO in regulation of pulmonary function may represent a novel physiological principle, namely that of an enzymatically produced airborne messenger. The term "aerocrine" may be appropriate for this action of NO in the airways. These findings may also help to explain one biological role of the enigmatic human paranasal sinuses, the major sources of NO in the upper airways. 4. A continuous production of NO takes place in the acidic stomach through chemical reduction of nitrite present in swallowed saliva. This is the first evidence of non-enzymatic NO production in humans. Stomach NO may be involved in local defence against swallowed pathogens and in regulation of superficial mucosal blood flow and mucus production. 5. Luminal concentrations of NO are increased in the lower airways of asthmatic children, in the colon of patients with inflammatory bowel disease, and in the urinary bladder of patients with cystitis. Local steroid treatment reduces orally exhaled NO levels in asthmatic children. Nasal NO levels did not differ between controls and asthmatic children with or without concomitant allergic rhinitis. In conclusion, nitric oxide found in exhaled air originates mainly in the upper airways. A large production of NO takes place in the paranasal sinuses from a constitutively-expressed, steroid-resistant "inducible-like" NO synthase in the epithelial cells. Sinus NO contributes substantially to levels of NO found in nasally exhaled air. Sinus NO may have a dual function. First, the very high concentrations in the sinuses may contribute to local host defence. Second, when diluted in the inhaled air, sinus-derived NO may act as an "aerocrine" messenger, with distal effects on pulmonary blood flow and oxygen uptake. Intubated patients are deprived of autogenous NO from the upper airways and might benefit from substitution. Measurements of local NO production in hollow organs may be done easily by analysing the concentrations of NO gas in luminal air. Such noninvasive methods may be useful not only to explore the role of NO in inflammation and host defence, but also in the diagnosis and monitoring of inflammatory mucosal diseases such as asthma, ulcerative colitis and cystitis. Thus, airborne NO may be looked upon as a marker of inflammation and as an aerocrine messenger in humans.

    Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Publishing Authors By Initials

    jo lundbergJO Lundberg,

    For similar reproductive and urinary physiology: urinary tract physiology research abstracts see: reproductive and urinary physiology: urinary tract physiology research

    PUBMED ID PMID:

    MEDLINE DATE:

    Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Acta physiologica Scandinavica. Supplementum

    VOLUME: 633

    Page Numbers: 1-27

    Journal Abbreviation:

    ISSN: 0302-2994

    DAY: 20

    MONTH: 02

    YEAR: 1996

    Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 376307

    Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Keywords Mesh Terms:

    KEYWORDS: Urinary Tract Physiology

    MESH TERMS: drug therapy

    Chemical & Substance for Abstract: Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Information

    Substance Name: Nitric Oxide Synthase

    Registry Number: EC 1.14.13.39

    Grant and Affiliation Information for Airborne nitric oxide: inflammatory marker and aerocrine messenger in man.

    AFFILIATION: Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.

    Country: ENGLAND

    ENGLAND Research PublicationENGLAND Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Acta Physiol Scand Suppl

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Airborne nitric oxide: inflammatory marker and aerocrine messenger in man Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News